Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.

Scientific reports - 3 Jan 2017

Molin Carl Johan, Westerberg Elisabet, Punga Anna Rostedt

Abstract excerpt

This study describes specific patterns of elevated inflammatory proteins in clinical subtypes of myasthenia gravis (MG) patients. MG is a chronic, autoimmune neuromuscular disease with antibodies most commonly targeting the acetylcholine receptors (AChRab), which causes fluctuating skeletal muscle fatigue. MG pathophysiology includes a strong component of inflammation, and a large proportion of patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Autoantibodies
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Inflammation

Share to Inflammation Mediators

Share to Myasthenia Gravis

Share to Receptors, Cholinergic

Share to Transforming Growth Factor alpha

Source

Open in PubMed Open full text

Identifiers

PMID: 28045063
DOI: 10.1038/srep39716
PMCID: PMC5206650

Genes

BDNF
CXCL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profile of upregulated inflammatory proteins in sera of Myasthenia Gravis patients.PMID 28045063Read ↗

Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized MedicineSemantic proximity Read ↗

A Distinct Immunological Signature in Late‐Onset Myasthenia Gravis: Insights from an Exploratory Proteomics StudySemantic proximity Read ↗

A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patientsSemantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

Clinical Genomic, phenotype and epigenetic insights into the pathology, autoimmunity and weight management of patients with Myasthenia Gravis (Review).Semantic proximity Read ↗

Myasthenia gravis: from autoantibodies to therapy.Semantic proximity Read ↗

Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot studySemantic proximity Read ↗

Complicating autoimmune diseases in myasthenia gravis: a review.Semantic proximity Read ↗

Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAsSemantic proximity Read ↗

The epidemiology of myasthenia gravis.Semantic proximity Read ↗

The autoimmune spectrum of myasthenia gravis: a Swedish population-based study.Semantic proximity Read ↗

Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.